Skip to main content
Top

Familial Cancer

Issue 4/2020

Content (10 Articles)

Open Access Breast Cancer Original Article

Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients

Jeanine A. M. van der Giessen, Margreet G. E. M. Ausems, Maria E. T. C. van den Muijsenbergh, Sandra van Dulmen, Mirjam P. Fransen

Salpingo-Oophorectomy Short Communication

Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report

Giovanni Grandi, Martina Caroli, Carlo Alboni, Laura Cortesi, Angela Toss, Elena Barbieri, Laura Botticelli, Fabio Facchinetti

Breast Cancer Original Article

Women’s responses and understanding of polygenic breast cancer risk information

T. Yanes, R. Kaur, B. Meiser, M. Scheepers-Joynt, S. McInerny, K. Barlow-Stewart, Y. Antill, L. Salmon, C. Smyth, P. A. James, M. A. Young

Open Access Breast Cancer Short Communication

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Pia Alhopuro, Reetta Vainionpää, Anna-Kaisa Anttonen, Kristiina Aittomäki, Heli Nevanlinna, Minna Pöyhönen

Endometrial Cancer Original Article

Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family

Ciyu Yang, Margaret Sheehan, Ester Borras, Karen Cadoo, Kenneth Offit, Liying Zhang

Original Article

MLH1 intronic variants mapping to + 5 position of splice donor sites lead to deleterious effects on RNA splicing

Tamara Alejandra Piñero, Omar Soukarieh, Marion Rolain, Karin Alvarez, Francisco López-Köstner, Giovana Tardin Torrezan, Dirce Maria Carraro, Ivana Lucia De Oliveira Nascimento, Thaís Ferreira Bomfim, Taísa Manuela Bonfim Machado-Lopes, Juliana Côrtes Freitas, Maria Betânia Toralles, Kiyoko Abe Sandes, Benedito Mauro Rossi, Samuel Aguiar Junior, Joanna Meira, Mev Dominguez-Valentin, Pål Møller, Carlos Alberto Vaccaro, Alexandra Martins, Walter Hernán Pavicic

Salpingo-Oophorectomy Original Article

Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics

B. Meiser, R. Kaur, J. Kirk, A. Morrow, M. Peate, W. K. T. Wong, E. McPike, E. Cops, C. Dowson, R. Austin, M. Fine, L. Thrupp, R. Ward, F. Macrae, J. E. Hiller, A. H. Trainer, G. Mitchell, R. Susman, N. Pachter, A. Goodwin, P. James, L. Mascarenhas, C. Morton, S. Shanley, M. A. Young, L. Andrews, E. A. Morrow, K. Tucker, G. Lindeman, M. Field, M. Monnik, N. Poplawski, M. Delatycki, T. John, M. Harris, R. Kerr, B. Vora

Melanoma Original Article

Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome

S. A. Nieuwenburg, F. Adan, M. W. G. Ruijs, G. S. Sonke, M. E. van Leerdam, M. B. Crijns

Neurofibromatosis Short Communication

Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1

Eliza Courtney, Sock Hoai Chan, Shao Tzu Li, Diana Ishak, Khurshid Merchant, Tarryn Shaw, Wen Yee Chay, Felicia Hui Xian Chin, Wai Loong Wong, Adele Wong, Joanne Ngeow

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine